BioCentury
ARTICLE | Clinical News

BioSpecifics regulatory update

July 5, 1994 7:00 AM UTC

BioSpecifics Technologies Corp. (BSTC) The Lynbrook, N.Y., company received notice of allowance for a U.S. Patent covering a topical powder form of its collagenase to treat dermal ulcers, wounds and ...